Israel Discount Bank of New York’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,846
Closed -$779K 90
2019
Q3
$779K Buy
7,846
+986
+14% +$93.7K 0.57% 49
2019
Q2
$634K Buy
6,860
+222
+3% +$21.1K 0.48% 53
2019
Q1
$626K Buy
6,638
+290
+5% +$25.4K 0.43% 50
2018
Q4
$407K Sell
6,348
-285
-4% -$21K 0.31% 65
2018
Q3
$594K Buy
6,633
+258
+4% +$22.8K 0.39% 57
2018
Q2
$506K Buy
6,375
+302
+5% +$25.1K 0.33% 64
2018
Q1
$542K Buy
6,073
+253
+4% +$24.3K 0.36% 58
2017
Q4
$607K Buy
5,820
+1,000
+21% +$113K 0.42% 55
2017
Q3
$703K Sell
4,820
-480
-9% -$65.4K 0.53% 41
2017
Q2
$688K Sell
5,300
-300
-5% -$36.8K 0.55% 43
2017
Q1
$697K Buy
5,600
+1,474
+36% +$176K 0.57% 47
2016
Q4
$478K Buy
+4,126
New +$459K 0.43% 54

Other funds holding CELG

Israel Discount Bank of New York's CELG Position: Q4 2019 in Review

Israel Discount Bank of New York sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,846 shares — an estimated $779K sold.

Israel Discount Bank of New York first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $779K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Israel Discount Bank of New York reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Israel Discount Bank of New York sold 7,846 Celgene Corp shares in Q4 2019, an estimated $779K.
  • Israel Discount Bank of New York first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Israel Discount Bank of New York's Celgene Corp position peaked at $779K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Israel Discount Bank of New York's 13F filing for Q4 2019, filed 14 Feb 2020.